| |
| |
|
| Insider
Information: |
Harsch Mutya |
| Relationship: |
|
| City: |
Rehovot |
| State: |
L3 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
149,274 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$33,363 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
149,274 |
|
|
| Total
Value |
$33,363 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Foamix Pharmaceuticals Ltd |
FOMX |
CLO and General Counsel |
2020-03-09 |
0 |
2019-01-01 |
0 |
Premium* |
|
|
VYNE Therapeutics Inc |
VYNE |
|
2024-04-01 |
149,274 |
2020-03-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VYNE |
VYNE Therapeutics Inc |
CHIEF LEGAL OFFICER AND GC |
• – – |
2024-04-01 |
4 |
D |
$3.08 |
$496 |
D/D |
(161) |
149,274 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Legal Officer and GC |
• – – |
2024-01-02 |
4 |
D |
$2.28 |
$367 |
D/D |
(161) |
149,435 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Legal Officer and GC |
• – – |
2024-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
62,500 |
149,596 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Legal Officer and GC |
• – – |
2023-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
62,500 |
87,096 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Legal Officer and GC |
• – – |
2023-10-02 |
4 |
D |
$3.83 |
$4,420 |
D/D |
(1,154) |
24,596 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Legal Officer and GC |
• – – |
2023-06-30 |
4 |
D |
$4.10 |
$644 |
D/D |
(157) |
25,750 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Legal Officer and GC |
• – – |
2023-05-31 |
4 |
A |
$3.46 |
$12,664 |
D/D |
3,664 |
25,907 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Legal Officer and GC |
• – – |
2023-03-20 |
4 |
B |
$2.50 |
$25,000 |
D/D |
10,000 |
22,721 |
2.74 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Legal Officer and GC |
• – – |
2022-12-31 |
4 |
D |
$0.15 |
$272 |
D/D |
(1,813) |
229,144 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Legal Officer and GC |
• – – |
2022-09-30 |
4 |
D |
$0.22 |
$404 |
D/D |
(1,813) |
230,957 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Legal Officer and GC |
• – – |
2022-06-30 |
4 |
D |
$0.39 |
$705 |
D/D |
(1,813) |
232,770 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Legal Officer and GC |
• – – |
2022-03-31 |
4 |
D |
$0.65 |
$2,360 |
D/D |
(3,630) |
234,583 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Legal Officer and GC |
• – – |
2022-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
238,213 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Legal Officer and GC |
• – – |
2021-12-31 |
4 |
D |
$1.02 |
$1,514 |
D/D |
(1,484) |
163,213 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Legal Officer and GC |
• – – |
2021-09-30 |
4 |
D |
$1.39 |
$2,063 |
D/D |
(1,484) |
164,697 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Legal Officer and GC |
• – – |
2021-09-02 |
4 |
A |
$0.00 |
$0 |
D/D |
60,859 |
166,181 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Legal Officer and GC |
• – – |
2021-06-30 |
4 |
D |
$3.51 |
$12,464 |
D/D |
(3,551) |
105,322 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Legal Officer and GC |
• – – |
2021-03-31 |
4 |
D |
$6.84 |
$12,073 |
D/D |
(1,765) |
108,873 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Legal Officer and GC |
• – – |
2021-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
29,213 |
110,638 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Legal Officer and GC |
• – – |
2020-12-31 |
4 |
D |
$1.58 |
$2,879 |
D/D |
(1,822) |
325,703 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Legal Officer and GC |
• – – |
2020-11-30 |
4 |
A |
$1.45 |
$15,115 |
D/D |
10,460 |
327,525 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Legal Officer and GC |
• – – |
2020-09-30 |
4 |
D |
$1.66 |
$3,025 |
D/D |
(1,822) |
317,065 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Legal Officer and GC |
• – – |
2020-06-30 |
4 |
D |
$1.73 |
$3,152 |
D/D |
(1,822) |
318,887 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Legal Officer and GC |
• – – |
2020-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
320,712 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Legal Officer and GC |
• – – |
2020-04-06 |
4 |
D |
$1.40 |
$6,264 |
D/D |
(4,474) |
170,712 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
